Skip to main content

Peer Review reports

From: Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW

Original Submission
3 Mar 2020 Submitted Original manuscript
14 Mar 2020 Reviewed Reviewer Report - Winfried Amoaku
20 Mar 2020 Reviewed Reviewer Report - Taichi Hikichi
3 Apr 2020 Author responded Author comments - Michel Weber
7 Apr 2020 Reviewed Reviewer Report - Winfried Amoaku
9 Apr 2020 Reviewed Reviewer Report - Taichi Hikichi
16 Apr 2020 Author responded Author comments - Michel Weber
Resubmission - Version 2
3 Apr 2020 Submitted Manuscript version 2
27 Apr 2020 Author responded Author comments - Michel Weber
Resubmission - Version 3
27 Apr 2020 Submitted Manuscript version 3
29 Apr 2020 Author responded Author comments - Michel Weber
Resubmission - Version 4
29 Apr 2020 Submitted Manuscript version 4
4 May 2020 Author responded Author comments - Michel Weber
Resubmission - Version 5
4 May 2020 Submitted Manuscript version 5
Publishing
8 May 2020 Editorially accepted
25 May 2020 Article published 10.1186/s12886-020-01468-z

You can find further information about peer review here.

Back to article page